BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37076962)

  • 1. UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer.
    Yin JY; Zhou Y; Ding XM; Gong RZ; Zhou Y; Hu HY; Liu Y; Lv XB; Zhang B
    Curr Cancer Drug Targets; 2024; 24(2):204-219. PubMed ID: 37076962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity.
    Min D; Lv XB; Wang X; Zhang B; Meng W; Yu F; Hu H
    Br J Cancer; 2013 Aug; 109(3):723-30. PubMed ID: 23820258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
    Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
    PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p.
    Zhou Y; Meng X; Chen S; Li W; Li D; Singer R; Gu W
    Breast Cancer Res; 2018 Apr; 20(1):32. PubMed ID: 29669595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA UCA1 regulates CCR7 expression to promote tongue squamous cell carcinoma progression by sponging miR-138-5p.
    Shi TT; Li R; Zhao L
    Neoplasma; 2020 Nov; 67(6):1256-1265. PubMed ID: 32749849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
    Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estrogen/miR-338-3p/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function.
    Shi Y; Pan J; Hang C; Tan L; Hu L; Yan Z; Zhu J
    Environ Toxicol; 2023 Jul; 38(7):1618-1627. PubMed ID: 37052432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ; Guo KY; Wei HM; Song CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.
    Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI
    Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of UCA1 Protects Against MPP
    Zheng Y; Liu J; Zhuang J; Dong X; Yu M; Li Z
    Neurochem Res; 2021 Apr; 46(4):878-887. PubMed ID: 33464446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143.
    Tuo YL; Li XM; Luo J
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3403-11. PubMed ID: 26439035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
    Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
    Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.
    Li X; Wu Y; Liu A; Tang X
    Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C; Luo J
    Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study.
    Kim HJ; Jeon S; Lee HJ; Bae J; Ri HS; Hong JM; Paek SI; Kwon SK; Kim JR; Park S; Yun EJ
    Korean J Anesthesiol; 2023 Dec; 76(6):627-639. PubMed ID: 37435613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
    Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
    Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
    El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
    Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.